Skip to main content

Connection Between HPV Risk and Hormonal Birth Control

There is some evidence suggesting a potential connection between hormonal birth control and an increased risk of human papillomavirus (HPV) infection. HPV is a sexually transmitted infection that can lead to various health issues, including cervical cancer. However, it's important to note that research findings are not entirely consistent, and more studies are needed to establish a definitive link. Some studies have suggested that hormonal contraceptives, such as birth control pills, may influence the risk of HPV infection. The hormonal changes caused by these contraceptives could potentially affect the immune system's response to infections, including HPV. It's worth noting that the relationship between hormonal contraceptives and HPV is complex, and other factors such as sexual behavior, number of sexual partners, and age at first sexual intercourse can also contribute to HPV risk. It's essential for individuals using hormonal birth control to be aware of their overall sexual health and to follow recommended preventive measures, such as regular screenings for HPV and cervical cancer. Additionally, individuals should discuss their contraceptive choices and any concerns about HPV with their healthcare providers. Healthcare professionals can provide personalized guidance based on an individual's health history and risk factors.
What else can cause or increase your risk of HPV and cervical cancer? Intimate sexual contact without a condom or other barrier method can increase your risk of HPV and other STIs. Although contracting HPV is the biggest risk factor for developing cervical cancer, this cancer can develop for a number of reasons. People who smoke cigarettes or use other tobacco products, for example, are more likelyTrusted Source to develop cancer of any kind. According to the American Cancer SocietyTrusted Source, the following can increase your risk of developing cervical cancer: having a weakened or compromised immune system taking immunosuppressant medications a past or current chlamydia infection having three or more full-term pregnancies having a full-term pregnancy before the age of 25 having a parent who took diethylstilbestrol while pregnant with you a family history of cervical cancer What can you do to help reduce your risk of HPV and cervical cancer when using hormonal birth control? Vaccinating against HPV can help reduce your risk of contracting high risk strains associated with genital warts and certain cancers. The Centers for Disease Control and Prevention (CDC)Trusted Source recommends vaccination at ages 11–12, but there are additional opportunities to get vaccinated later in life. For example, people ages 15–26 can benefit from a three-dose protocol. Consult a healthcare professional to learn more if you’re between 27 and 45. While not always recommended for this age group, your doctor may recommend it based on your individual needs. Internal and external condoms are the only form of birth control that can help reduce the risk of STIs. So, one thing you can do to reduce your risk of HPV is to use condoms, says Ton. “You should also use barrier protection (like condoms or dental dams) during oral sex,” adds Ton. Routine Pap smears can help you stay on top of any unusual changes. The American College of Obstetricians and Gynecologists recommends getting a Pap smear once every 3 years, beginning at age 21. Healthcare professionals typically do not recommend separate HPV testing unless you have an abnormal Pap smear result. “Other precautions include reducing activities that weaken the immune system, like smoking, and getting conditions that affect the immune system, like HIV or diabetes, under control,” says Denny.

Comments

Popular posts from this blog

Ignoring influenza and flu in winter can be Dangerous

Ignoring influenza (the flu) and flu-like symptoms during the winter can indeed be dangerous. Influenza is a viral infection that primarily spreads through respiratory droplets when an infected person coughs or sneezes. It tends to be more prevalent during the colder months, which is why it's often associated with winter. Here are some reasons why ignoring the flu in winter can be dangerous: Complications: The flu can lead to serious complications, especially in vulnerable populations such as young children, the elderly, pregnant women, and individuals with weakened immune systems. Complications can include pneumonia, bronchitis, sinus infections, and ear infections. Spread of the Virus: Influenza is highly contagious, and neglecting symptoms can contribute to the spread of the virus to others. This is particularly concerning in crowded places like schools, offices, and public transportation. Weakened Immune System: The winter season itself can weaken the immune system, making ...

What Is a Secondary Headache?

A secondary headache is a type of headache that is a symptom of another underlying medical condition or disease. Unlike primary headaches, which are not associated with any underlying cause, secondary headaches are a result of an identifiable and usually serious underlying problem. There are numerous potential causes of secondary headaches, including: Head Injury: Traumatic head injuries can lead to headaches as a symptom. Sinusitis: Inflammation of the sinuses can cause pain and pressure in the head. Migraines: While migraines can be primary headaches, they can also be secondary if they are triggered by an underlying condition. Medication Overuse: Excessive use of pain medications, especially those containing caffeine or codeine, can lead to rebound headaches. Infection: Various infections, such as meningitis, encephalitis, or a sinus infection, can cause secondary headaches. High Blood Pressure: Hypertension (high blood pressure) can lead to headaches, especially if it is seve...

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is mad...